FA complementation group G
Last updated 3 Mar 2025
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The FANCG gene provides instructions for making a protein that is involved in a process known as the Fanconi anaemia (FA) pathway. The FA pathway turns on (activates) when the process of making new copies of DNA, called DNA replication, is blocked due to DNA damage. The FA pathway works to prevent a certain type of DNA damage known as interstrand cross-links (ICLs). ICLs are abnormal connections between two DNA building blocks (nucleotides) on opposite strands of DNA. These cross-links stop the process of DNA replication and can be caused by a buildup of toxic substances produced in the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents).
Video picks for GenesVideo library
Normal function
The FANCG gene provides instructions for making a protein that is involved in a process known as the Fanconi anaemia (FA) pathway. The FA pathway turns on (activates) when the process of making new copies of DNA, called DNA replication, is blocked due to DNA damage. The FA pathway works to prevent a certain type of DNA damage known as interstrand cross-links (ICLs). ICLs are abnormal connections between two DNA building blocks (nucleotides) on opposite strands of DNA. These cross-links stop the process of DNA replication and can be caused by a buildup of toxic substances produced in the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents).
The FANCG protein is one of several proteins that form a group known as the FA core complex. The FA core complex is composed of eight FA proteins (including FANCG) and two proteins called Fanconi anaemia-associated proteins (FAAPs). This complex activates two proteins, called FANCD2 and FANCI, by attaching a single molecule called ubiquitin to each of them (a process called monoubiquitination). The activation of FANCD2 and FANCI attracts DNA repair proteins to the area of DNA damage so the cross-link can be corrected and DNA replication can continue.
Conditions referring to this gene or chromosome
Other names
FANCG_HUMAN
Fanconi anaemia, complementation group G
XRCC9
Patient picks for Genes

Signs and symptoms
Fainting
Fainting is a temporary loss of consciousness that happens when the brain does not receive enough oxygen because of reduced blood flow to the brain. It comes on suddenly, only lasts for a short time and you recover fully within a short time. It is also often called a blackout. The medical term is syncope. It isn't the same thing as a seizure which usually causes jerking. It is important to seek medical attention if you experience faints. Faints may be caused by a serious problem. However, this is unusual. The most common causes are mentioned below.
by Dr Colin Tidy, MRCGP

Women's health
Ferritin face - signs of low iron, or viral skin trend?
There’s a new viral wellness term in town called ‘ferritin face’. It’s being used to describe the apparent link between low iron stores and symptoms such as dark circles under your eyes, dull, tired-looking skin, cracked lips, and hair loss. But what exactly is ferritin, and can low levels really affect your facial appearance? We spoke to consultant gynaecologist, Dr Lamia Zafrani, and consultant dermatologist, Dr Sidra Khan, to demystify what ferritin is, how it affects our bodies, and why women are more vulnerable to lower levels.
by Hannah Boynton-Forshaw

Digestive health
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) describes a range of conditions caused by a build-up of fat within liver cells.
by Dr Doug McKechnie, MRCGP

Healthy living
Mounjaro weight loss injections: FAQs
While weight loss injections such as Mounjaro can be incredibly helpful for some people, they’re also just one piece of the puzzle when it comes to long-term metabolic health. Understanding what they can and can’t do, and how they work, can help guide your decision-making if you’re thinking about trying them. Here are answers to some of the most common questions patients ask about Mounjaro.
by Dr Nienke Lees

Heart health and blood vessels
Heart failure
Heart failure does not mean that your heart has stopped or is going to stop at any minute. It means that your heart is not functioning as well as it should. Heart failure can be caused by many different conditions. Symptoms include fluid retention, breathlessness and tiredness. Medication can usually ease symptoms and can often improve the outlook.
by Dr Colin Tidy, MRCGP

Heart health and blood vessels
Pulmonary oedema
Pulmonary oedema is an excess of watery fluid in the lungs. People with sudden onset of pulmonary oedema usually need urgent admission to hospital. Treatment includes oxygen, medicines to remove the excess fluid from the lungs (diuretics), and other medicines to help the heart work more effectively. Further treatment will depend on the cause of the pulmonary oedema. Pulmonary oedema may be life-threatening, especially without urgent medical treatment.
by Dr Rosalyn Adleman, MRCGP
Related patient information and medicines

Patient information leaflet
Blood tests
The main reasons to know your blood group are if you need to have a blood transfusion or if you are pregnant. You cannot request a blood test just to know your blood group on the NHS. What is blood made up of. Blood cells These can be seen un... Blood sugar (glucose) level. HbA1c blood test Blood glucose test (blood sugar) and HbA1c - this is a.

Patient information leaflet
Neonatal jaundice
Neonatal jaundice is very common in the first two weeks of a baby's life. It is usually harmless but may be due to a serious cause which needs treatment in hospital. Neonatal jaundice is more likely to have a serious cause if it is seen in the first 24 hours of life or doesn't disappear by 2 weeks of age. All babies with jaundice should be seen by.

Patient information leaflet
Fainting
Fainting is a temporary loss of consciousness that happens when the brain does not receive enough oxygen because of reduced blood flow to the brain. Driving and faints The Driver and Vehicle Licensing Agency (DVLA) rules on dr... For Group 1 (car and motorcycle) license holders, 'simple' faints (vasovagal syncope) that occur only whilst standing.

Patient information leaflet
Immunisation for flu
The live attenuated flu vaccine comes as a nasal spray... Each year, the UK national flu vaccine programme gives instructions on which type of vaccine should be given to each group of people. Who is eligible for the flu jab. The Department of Health issues advice as to who should be immunised. This is reviewed each year. The aim is to protect.

Patient information leaflet
Laxatives
Laxatives are medicines that are used to treat constipation. They can be taken by mouth as liquids, tablets, capsules, powders that dissolve in water, or they can be given via the back passage (rectum). What are laxatives. Laxatives are a group of medicines that are used to treat constipation. They can be taken by mouth as liquids, tablets,.

Patient information leaflet
Find out if you are eligible for a free NHS flu vaccination
Open the flu jab Is the flu vaccine free for you this winter. The flu vaccine is free on the NHS for people most likely to get seriously ill from flu, and for those who could easily pass it on to someone at risk. Whether you qualify depends on your age, your health, and a few other things such as being pregnant or caring for someone. The groups.
Further reading and references
- FA complementation group G; MedlinePlus, National Library of Medicine.
- de Winter JP, Joenje H. The genetic and molecular basis of Fanconi anemia. Mutat Res. 2009 Jul 31;668(1-2):11-9. doi: 10.1016/j.mrfmmm.2008.11.004. Epub 2008 Nov 14.
- Deakyne JS, Mazin AV. Fanconi anemia: at the crossroads of DNA repair. Biochemistry (Mosc). 2011 Jan;76(1):36-48. doi: 10.1134/s0006297911010068.
- Kee Y, D'Andrea AD. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev. 2010 Aug 15;24(16):1680-94. doi: 10.1101/gad.1955310.
- Kitao H, Takata M. Fanconi anemia: a disorder defective in the DNA damage response. Int J Hematol. 2011 Apr;93(4):417-424. doi: 10.1007/s12185-011-0777-z. Epub 2011 Feb 18.
- Mathew CG. Fanconi anaemia genes and susceptibility to cancer. Oncogene. 2006 Sep 25;25(43):5875-84. doi: 10.1038/sj.onc.1209878.
- Mehta PA, Ebens CL. Fanconi Anemia. 2002 Feb 14 [updated 2026 Jan 15]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1401/
- Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood. 2006 Jun 1;107(11):4223-33. doi: 10.1182/blood-2005-10-4240. Epub 2006 Feb 21.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

